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Running title: GABAB receptors in hippocampal CCK interneurons

Abstract
Cholecystokinin-expressing interneurons (CCK-INs) mediate behavioural state-dependent inhibition in cortical circuits, but themselves receive strong GABAergic input. However, it remains unclear to what extent GABAB receptors (GABABRs) contribute to their inhibitory control. Using immunoelectron microscopy we found that CCK-INs in the rat hippocampus possessed high levels of dendritic GABABRs and KCTD12 auxiliary proteins, whereas postsynaptic effector Kir3 channels were present at lower levels. Consistently, whole-cell recordings revealed slow GABABR-mediated inhibitory postsynaptic currents (IPSCs) in most CCK-INs. In spite of the higher surface density of GABABRs in CCK-INs than in CA1 principal cells, the amplitudes of IPSCs were comparable suggesting that expression of Kir3 channels is the limiting factor for the GABABR currents in these INs. Morphological analysis showed that CCK-INs were diverse, comprising perisomatic-targeting basket cells (BCs), as well as dendrite-targeting (DT) interneurons, including a novel DT type. GABABR-mediated IPSCs in CCK-INs were large in BCs, but small in DT subtypes. In response to prolonged activation GABABR-mediated currents displayed strong desensitization, which was absent in KCTD12-deficient mice. This study highlights that GABABRs differentially control CCK-IN subtypes, and the kinetics and desensitization of GABABR-mediated currents are modulated by KCTD12 proteins.
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Introduction
Hippocampal microcircuits are regulated by a cohort of inhibitory GABAergic interneurons (INs) with diverse neurochemical, physiological and morphological properties (Freund and Buzsáki 1996; Klausberger and Somogyi 2008). INs containing the neuropeptide cholecystokinin (CCK) (Kosaka et al. 1985; Nunzi et al. 1985; Sloviter and Nilaver 1987) are believed to control the input and output of pyramidal cells (PCs) in a behavior state-dependent manner (Klausberger et al. 2005; Puighermanal et al. 2009; Basu et al. 2013) and contribute significantly to hippocampal network oscillations (Klausberger et al. 2005; Lasztoczi et al. 2011). Thus, they can regulate information propagation through the hippocampal circuit, as well as being involved in pathogenic brain states, such as epilepsy and anxiety disorders (Freund and Katona 2007; ). CCK-INs are regular-spiking, discharging at moderate frequencies both in vitro and vivo (), participating in both theta (4-12 Hz) and gamma (25-100 Hz) activities (Klausberger et al. 2005; Tukker et al. 2007). In the hippocampus, CCK-INs show large morphological diversity  ADDIN EN.CITE (; ; ) and can be classified as either perisomatic-targeting basket cells (BCs) or dendrite-targeting (DT) cells. Of the latter two subtypes, Schaffer collateral-associated (SCA) and perforant path-associated (PPA) cells have been previously described in the CA1 area  ADDIN EN.CITE (Vida et al. 1998; ; ; ; ; , Szabo et al. 2014).
CCK-INs are embedded in hippocampal networks, mediating both feedforward and feedback inhibition receiving both excitatory and inhibitory synaptic inputs, with inhibition markedly stronger than on other IN types (). Inhibition onto CCK-INs is primarily mediated by ionotropic GABAA receptors (GABAARs), partially arising from CCK-positive mutual inhibitory connections (Nunzi et al. 1985; Mátyás et al. 2004). The contribution of metabotropic GABABRs to the postsynaptic inhibitory profile of CCK-INs has not been investigated. Previous in situ hybridization and immunocytochemical studies have shown that the GABAB1 subunits are expressed in the somata of many hippocampal INs  ADDIN EN.CITE (; ), at particularly high levels in CCK-INs (). These data thus suggest an important role for GABABRs in modulating the activity of these INs ().
GABABRs are obligate heterodimers composed of the GABAB1 and GABAB2 subunits (). On postsynaptic membranes, functional GABABRs colocalize and interact with G-protein-coupled inwardly-rectifying K+ (Kir3) channels, which mediate hyperpolarizing currents controlling neuronal excitability (; Lujan et al. 2009). GABABRs further associate with auxiliary K+-channel tetramerization domain-containing (KCTD) proteins, of which KCTD12 accelerates onset and desensitization of GABABR-Kir3 currents  ADDIN EN.CITE (; Gassmann and Bettler 2012; ). However the subcellular organization of these signaling proteins and their interactions on postsynaptic membranes of CCK-INs have remained unknown. Therefore, in this study we assessed the expression and function of GABABRs and their postsynaptic effectors in identified CCK-INs.

Materials and Methods

Antibodies and Controls
Affinity-purified and characterized polyclonal rabbit (B17, Kulik et al. 2002) or guinea pig (B62, Kulik et al. 2006) antibodies were used to detect the GABAB1 receptor subunit. The Kir3 channel subunits, Kir3.1, Kir3.2, and Kir3.3, were detected by using polyclonal antibodies (Alomone Labs, Jerusalem, Israel, Frontier Science, Japan) raised in rabbits. These antibodies were previously extensively characterized and their specificity confirmed (Kulik et al. 2006; Ciruela et al. 2010)(Kulik et al., 2002; Kulik et al., 2006). KCTD12 was detected with a polyclonal antibody raised in rabbits (Pineda Labs, Berlin, Germany), which has also been thoroughly characterized previously (Schwenk et al. 2010)(Schwenk et al., 2010; Metz et al., 2011).
CCK-INs were identified with (1) a rabbit polyclonal antibody detecting pro-CCK peptide (Code L424; characterized in Morino et al. 1994), (2) a mouse monoclonal antibody raised against CCK/Gastrin (generous gifts from: Dr. G Ohning, CURE, UCLA, CA; Savanthrapadian et al. 2014), or (3) a novel rabbit polyclonal antibody against pre-pro-CCK. The latter antibody was produced against synthetic peptide CSAEDYEYPS (107-115 amino acid residues of mouse pre-pro-CCK, GenBank accession number X59521.1) conjugated to keyhole limpet hemocyanin by the m-maleimidobenzoic acid N-hydroxysuccinimide ester method and affinity-purified using the peptide. The specificity was confirmed by intense labeling in the same populations of cortical and hippocampal interneurons by fluorescence in situ hybridization for pre-pro-CCK mRNA and immunofluorescence using the pre-pro-CCK antibody (Supplementary Fig. 1).
Background labeling. To validate the specificity of immunolabeling for GABAB1 and Kir3 channel subunits in CCK-INs we determined the density of immunoparticles over mitochondria in each sample: the mean background labeling for GABAB1 was 1.1 ± 0.6 particles/m2 (152 mitochondria), for Kir3.1 1.6 ± 0.4 particles/m2 (147 mitochondria), for Kir3.2 0.4 ± 0.2 particles/m2 (181 mitochondria), and finally for Kir3.3 0.3 ± 0.2 particles/m2 (231 mitochondria). For all antibodies the labeling intensity at the membrane of both PCs and CCK-INs was significantly higher than the background (mean density of immunogold particles calculated for the section surface at the inner leaflet of the membrane of CCK dendrites within 25 nm were 85.2 ± 5.1 particles/m2 for GABAB1, 20.4 ± 2.4 particles/m2 for Kir3.1, 8.2 ± 1.7 particles/m2 for Kir3.2, and 6.2 ± 2.0 particles/m2 for Kir3.3; P<0.0001 for all, except for Kir3.3 where P=0.03, one-way ANOVA with Bonferroni post-tests).

Immunocytochemistry
Tissue Preparation 
Ten adult male Wistar rats were used for morphological analysis in the present study. All procedures and animal maintenance were performed in accordance with Institutional, U.K. Home Office guidelines (Schedule 1 of the Scientific Procedures Act; 1986), the German Animal Welfare Act, local authorities (Registration numbers: T0215/11, X-14/11H in Berlin and Freiburg, respectively) and the European Council Directive 86/609/EEC. Animals were anesthetized with Narkodorm-n (180 mg/kg, i.p.) (Alvetra GmbH, Germany) and transcardially perfused as described previously (Booker et al. 2013)(Kulik et al., 2003; Booker et al., 2013). For light microscopic analysis (n=6 rats) the fixative solution comprised 4% paraformaldehyde (Merck, Darmstadt, Germany) in 0.1 M phosphate buffer (PB). For electron microscopic analysis, 4 rats were fixed with the same fixative, albeit also containing 0.05% glutaraldehyde (Polyscience, Warrington, PA) and 15% (v/v) saturated picric acid. 

Double and Triple Immunofluorescence Labeling for Light Microscopy 
Sections including the hippocampus were cut at 50 μm on a vibratome (VT1000, Leica, Wetzlar, Germany), then extensively rinsed in 25 mM PB containing 0.9% NaCl (PBS). Sections were then blocked against non-specific antibody binding and permeabilized in PBS containing 10% normal goat serum (NGS, Vector Laboratories, Burlingame, CA) and 0.3% Triton X-100 for 1 hr at room temperature. Sections were then incubated with primary antibodies (GABAB1 [B62]: 1 µg/ml, Kir3.1: 1 µg/ml, Kir3.2: 1 µg/ml, Kir3.3: 1 µg/ml), which were diluted in PBS containing 5% NGS, 0.3% Triton X-100 and 0.05% NaN3, at 4˚C for 48-72 hr. The anti-CCK antibodies were applied at a dilution of 1:5000 (CCK/Gastrin, mouse) or 1:1000 (pro-CCK, rabbit). Sections were extensively rinsed in PBS, then incubated with fluorescence secondary antibodies (anti-guinea pig-conjugated Alexa Fluor 546 and anti-rabbit-conjugated Alexa Fluor 488 in double-labeling experiments, as well as anti-guinea pig Alexa Fluor 546, anti-mouse Alexa Fluor 488 antibodies, and anti-rabbit-conjugated Alexa Fluor 647 in triple-labeling experiments, 1:500; Invitrogen, Darmstadt, Germany) in PBS containing 3% NGS, at 4˚C overnight (O/N). Subsequently, sections were rinsed in PBS then in PB and embedded in a fluorescence mounting medium (Anti-fade, Invitrogen) under cover slips.

Pre-embedding Immunoelectron Microscopy
Sections for double-labeling immunoelectron microscopy were prepared as described previously (Kulik et al. 2003)(Kulik et al., 2003; Booker et al., 2013). Briefly, 50 μm hippocampal sections freeze/thaw permeabilized, then blocked and incubated in primary antibodies as above (GABAB1 (B17): 2 µg/ml; GABAB1 (B62): 2 µg/ml; Kir3.1: 1.5 µg/ml, Kir3.2: 2.5 µg/ml, Kir3.3: 12.5 µg/ml, KCTD12: 2 µg/ml) in combination either with anti-pro-CCK antibody (1:1000, rabbit) or CCK/Gastrin antibody (1:3000, mouse) in 0.05 M Tris-buffered saline (TBS) containing 3% NGS, at 4°C O/N. Sections were then rinsed in TBS and incubated with a mixture of gold-coupled (Fab fragment, diluted 1:100; Nanoprobes, Stony Brook, NY) and biotinylated (diluted 1:50, Vector Laboratories) secondary antibodies at 4°C O/N. The sections were rinsed in TBS and then in distilled water. Nanogold particles were enhanced with silver using a HQ Silver kit (Nanoprobes) and then incubated with avidin-biotinylated peroxidase complex (ABC kit, Vector Laboratories). Biotin was visualized by the chromogen 3,3-diaminobenzidine tetrahydrochloride (DAB; 0.05%) with 0.01% H2O2 as the substrate. Sections were postfixed and contrasted with 1% OsO4 and uranyl acetate, dehydrated in ethanol and propylene oxide then embedded in epoxy resin (Durcupan ACM, Fluka, Sigma-Aldrich, Gillingham, UK). Ultrathin sections were cut on an ultramicrotome (Reichert Ultracut E, Leica, Austria), observed using a Philips CM100 electron microscope. Images were taken with a CCD camera (Orius SC600, GATAN Inc.) and acquired with GATAN software. 

Quantification of Immunogold Labeling
Serial ultrathin sections were cut from the very surface of the tissue (up to 3 µm depth), due to the limited penetration of gold-coupled antibodies (Kulik et al. 2002). CCK-immunoperoxidase labeled dendrites and unlabeled spiny PC dendritic shafts were imaged in str. radiatum of CA1. Immunogold density was calculated by dividing the number of immunogold particles on the inner leaflet of the plasma membrane (located within 25 nm from the membrane) and the surface area of dendritic profiles. The surface area of plasma membrane was determined by measuring the perimeter of dendritic profiles (ImageJ software, W.S. Rasband, U. S. National Institutes of Health, Bethesda, Maryland, http://rsb.info.nih.gov/ij/) and multiplying it by the nominal ultrathin section thickness of 65 nm. 

Electrophysiology
For whole-cell patch-clamp recordings, acute hippocampal slices were prepared from 17-28 day-old wild-type Wistar rats or Wistar rats expressing Venus/YFP under the vesicular GABA transporter (VGAT) promoter (n=48 rats) (Uematsu et al. 2008). In a subset of experiments 8-10 week-old C57BL/6 x 129 mice homozygous for a KCTD12-knock-out allele (n=6) and wild-type littermates (n=5) were used (Cathomas et al. 2015). 

Acute Hippocampal Slice Preparation
Slices were prepared as previously described (Booker et al. 2014)(Booker et al., 2013; Booker et al., 2014). Briefly, following either cervical dislocation or direct decapitation, brains were rapidly removed and placed in carbogenated (95% O2 / 5% CO2), ice-cold sucrose-ACSF (in mM: 87 NaCl, 2.5 KCl, 25 NaHCO3, 1.25 NaH2PO4, 25 glucose, 75 sucrose, 7 MgCl2, 0.5 CaCl2, 1 Na-Pyruvate, 1 Ascorbic Acid). Transverse hippocampal slices (300 μm thick) were cut on a vibratome (VT1200S, Leica Instruments) and transferred to a submerged holding chamber containing carbogenated sucrose-ACSF. Slices were incubated at 35ºC for 30 min then subsequently stored at room temperature. Slices were transferred to a submerged chamber for recording and superfused with carbogenated, normal ACSF (in mM: 125 NaCl, 2.5 KCl, 25 NaHCO3, 1.25 NaH2PO4, 25 glucose, 1 MgCl2, 2 CaCl2, 1 Na-Pyruvate, 1 Ascorbic Acid) at 32-34ºC. 

Whole-cell Patch-clamp Recordings
Hippocampal slices were visualized with an upright microscope (BX-50-WI, Olympus, Hamburg, Germany) under infrared differential interference contrast (IR-DIC) optics and a digital camera (Till Photonics IR-CCD, Gräfelfing, Germany or Zyla 4 scientific cMOS camera, Andor, Belfast, UK). Whole-cell recording electrodes were produced from borosilicate glass capillaries (2 mm outer / 1 mm inner diameter; Hilgenberg, Malsfeld, Germany) with a horizontal puller (P-97, Sutter Instrument Company, Novato, CA). Pipettes were filled with K-gluconate based solution (in mM: 130 K-Gluc, 10 KCl, 2 MgCl2, 10 EGTA, 10 HEPES, 2 Na2-ATP, 0.3 Na2-GTP, 1 Na2-Creatinine, 0.1% biotinylated-lysine (Biocytin, Invitrogen, UK), pH 7.3, 290 – 310 mOsm) and had a resistance of 2-5 MΩ.
Recordings were performed using either an AxoPatch 200B or Multiclamp 700B amplifier (Molecular Devices, Sunnyvale, CA). Voltage and current signals were low-pass filtered at 1-10 kHz using the built in Bessel filter of the amplifiers, digitized at 20 kHz (CED 1401, Cambridge Instruments, U.K or NI-DAQ, National Instruments, Newbury, UK) and acquired with WinWCP software (courtesy of J. Dempster, Strathclyde University, UK). Data was analysed offline using the Stimfit software package (courtesy of C. Schmidt-Hieber; http://www.stimfit.org (​http:​/​​/​www.stimfit.org​/​​); Guzman et al. 2014). 
Once whole-cell configuration was achieved, intrinsic physiology of neurons was recorded in current-clamp mode with a series of current pulses (‑250 to 250 pA, 50 pA steps, 500 ms duration). Pharmacologically-isolated GABABR-mediated IPSCs were elicited in the presence of ionotropic receptor blockers: DNQX or NBQX (both at 10 μM), APV (50 μM) and bicuculline or gabazine (SR-95531; both at 10 μM) in the voltage-clamp mode (holding potential: -65 mV) by extracellular stimulation. Stimulating electrodes were patch pipettes filled with 2 M NaCl (resistance 0.1 – 0.3 MΩ) positioned at the border of str. radiatum/lacunosum-moleculare, approximately 100 m distal from the axis of the recorded neuron, towards CA3. Stimuli had duration of 0.1-0.2 ms, with an intensity of 50 V applied by a constant-voltage isolated stimulus generator (Digitimer DSA2, Cambridge, UK). As we have shown previously (Booker et al. 2013) extracellular stimulation resulted in robust GABABR/Kir3-mediated responses in PCs from either single stimuli or 200 Hz trains of 3 or 5 pulses and collecting evoked responses every 20 s. Series resistance (RS) was constantly monitored throughout recordings, through applying a test pulse at the end of each sweep, but was not compensated. Recordings were abandoned if initial RS exceeded 30 MΩ or changed by more than 20% over the timecourse of the recording. The average RS was 16.8 ± 0.8 MΩ (Range: 5.6 – 28.0 MΩ), which was not significantly different between the groups of recorded neurons (P=0.51, 1-way ANOVA). Cells with dendrites significantly cut or truncated by the slice preparation, were excluded from further analysis. 
Peak IPSC amplitude was measured over a 10 ms time window from baseline level directly preceding the stimulus, from an average of at least 10 IPSC traces. In some INs, we observed a small inward-current in the presence of ionotropic receptors, which had a much faster time course and did not interfere with the peak of the slower GABABR-mediated IPSC. In a subset of experiments, the concentration of ionotropic blockers was doubled, but did not reduce the amplitude of this current, which was not further identified.
GABABR/Kir3-mediated whole-cell currents were analyzed through bath application of the selective GABABR agonist baclofen (10 μM). The peak outward-current produced by baclofen application was measured as the change in holding-current between the 2 minute baseline directly preceding drug application and the maximal response over a 1 minute window following drug wash-in, in experiments where a clear peak could not be observed, the peak was recorded over the same 1 minute window as for cells where a clear peak was observed. GABABR/Kir3-mediated currents were blocked by bath application of the selective GABABR antagonist CGP-55845 (CGP, 5 μM). Baclofen-mediated desensitization of GABABR/Kir3-mediated currents was assessed, as described previously (Schwenk et al. 2010), as the percentage change in baclofen-induced current at steady-state activity, 9-10 minutes following agonist application, relative to the peak baclofen current (<1 minute following presence of baclofen in the recording chamber). In this analysis we included data obtained under identical conditions from additional CA1 PCs (16 further cells) and parvalbumin-containing BCs (11 cells) that were published recently (Booker et al. 2013), where only peak baclofen current was assessed previously. 

Visualization and Immunocytochemical Characterization of Recorded Neurons
Following recording, slices were immersion fixed in 4% paraformaldehyde overnight and histologically processed as described previously (Booker et al. 2014)(Booker et al., 2013; Booker et al., 2014). In brief, biocytin-filled cells were visualized using avidin-conjugated Alexa Fluor 647 (Invitrogen; 1:1000) and processed for immunofluorescence labeling for CCK using the mouse monoclonal CCK/Gastrin antibody at a dilution of 1:5000 (rat slices) or the rabbit polyclonal pre-pro-CCK antibody (Supplementary Fig. 1) at a dilution of 1:1000 (mouse slices), followed by a fluorescence secondary antibody (Alexa Fluor 488 or 546, 1:500, Invitrogen). Slices were mounted in a polymerizing fluorescence mounting medium and coverslipped including a 300 μm agar spacer to minimize shrinkage of the slices. Morphological and immunocytochemical analysis of the cells was performed on a confocal laser-scanning microscope (FluoView 1000, Olympus, Japan). Immunofluorescence for CCK was assessed with a silicone-immersion x63 (NA 1.3) objective. All INs included in this study showed immunoreactivity for CCK in somatic cytoplasm, proximal dendrites or axon terminals. 
A subset of INs, (3 BCs and 3 LA cells) were selected for labeling for CB1 receptor, known to be highly expressed in axon terminals of CCK INs (Katona et al. 1999). For this purpose, slices were removed from the slides and rinsed extensively before re-sectioning them at 70 m on a cryostat. The sections were then blocked as above, and incubated in a solution containing polyclonal rabbit primary antibody against CB1 receptor at a dilution of 1:800 (Fukudome et al. 2004) and visualized by a fluorescence secondary antibody (anti-rabbit Alexa Fluor 405, 1:500, Invitrogen). Sections were mounted in a polymerizing fluorescence mounting medium, coverslipped and analyzed on a confocal laser-scanning microscope as above.

Morphological Analysis
Selected neurons with their complete axon were 3-dimensionally reconstructed using the Simple Neurite Tracer plug-in in the FIJI distribution of ImageJ software (Longair et al. 2011; http://fiji.sc/) from confocal image stacks obtained with a x20 objective (NA 0.75). Axonal and dendritic distributions were assessed by segmenting the individual lamina in 3 dimensions then using the layer boundaries to define neurite skeleton length in each layer, normalized to the total axonal or dendritic length in order to calculate their distribution across the layers.

Statistical Analysis
All values are given as mean ± standard error of the mean (SEM). Statistical analyses were performed using the GraphPad 3.0 (Prism, La Jolla, CA) software package. Unpaired and paired comparisons were performed with the Mann-Whitney and Wilcoxon matched-pairs signed rank tests, respectively. Multiple group comparisons were performed first using the Kruskal-Wallis rank sum test or 2-way ANOVA, with Bonferroni post tests. Statistical significance (P) was accepted at < 0.05.

Results
CCK-INs Show Labeling for GABAB1 and Kir3 Channel Subunits
Previous publications have shown that subpopulations of hippocampal INs, in particular CCK-INs, show strong somatic immunoreactivity for GABAB1  ADDIN EN.CITE (; ). In order to confirm that CCK-INs in the CA1 of the hippocampus expressed GABAB1 as well as postsynaptic effector Kir3 channel subunits, we have first performed double immunofluorescence labeling for CCK and either GABAB1 alone or triple labelings for CCK, GABAB1 and one of the Kir3.1-3.3 subunit isoforms. As described previously ( ADDIN EN.CITE Kulik et al. 2006; ), immunostaining for the GABAB1 and Kir3 subunits resulted in a characteristic pattern over the neuropil, with strong labeling observed in str. lacunosum-moleculare. In the CA1 area, the cell body layer showed moderate, but clear labeling (Fig. 1A,B), plausibly corresponding to the receptor and channel proteins localized to the endoplasmic reticulum in the somata of PCs (Kulik et al. 2003). The majority of observed CCK-IN somata were strongly labeled for GABAB1 (Fig. 1A,C), with consistently higher intensity of immunoreactivity than nearby CA1 PCs and the neuropil (Fig. 1A,C; P<0.0001, Bonferroni’s multiple comparison test). The immunofluorescence signal for the Kir3 channel subunits was more variable in CA1 PCs and CCK-INs. While Kir3.1 showed strong immunofluorescence labeling in the somata of CCK-INs, above that of neuropil and CA1 PC somata (P=0.0024 vs CA1 PC, Bonferroni’s multiple comparisons test, Fig. 1B,C), immunoreactivity for Kir3.2 and Kir3.3 was below that of neuropil labeling (Fig. 1B,C). Indeed, no statistical difference in the intensity of immunoreactivity for Kir3.2 and Kir3.3 was observed between either cell types (Fig. 1B,C, P=0.99 and 0.20, respectively). These data suggest that CCK-INs possess GABABRs and Kir3 channels at levels comparable or higher than CA1 PCs.

The GABAB1 Subunit Is Abundant on CCK-IN Dendrites
To investigate whether the observed strong somatic immunofluorescence signal for GABAB1 is correlated with high expression of dendritic surface-localized receptors, we next performed high-resolution pre-embedding immunogold labeling for GABAB1 in combination with immunoperoxidase labeling for CCK. Consistent with previously published data (Kulik et al. 2003), immunogold particles for GABAB1 localized to the plasma membrane of unlabelled spiny dendrites of CA1 PCs and at a lower level to axon terminals forming symmetric and asymmetric synapses in str. radiatum of CA1. 
In immunoperoxidase-labelled CCK dendrites, we observed high numbers of immunogold particles for GABAB1 (Fig. 2A). The surface density of the receptor subunit on CCK-positive dendrites was two-fold higher than on spiny, putative CA1 PC dendrites in the same section: on CCK dendrites the mean density was 32.8 ± 3.5 particles/μm2 (23 dendrites, 2 rats), whereas in CA1 PC dendritic shafts it was 15.4 ± 2.1 particles/μm2 (19 dendrites, P=0.0008; Fig. 2B). These data demonstrate that CCK-IN dendrites express a high density of surface-localized GABABRs, capable of forming functional heterodimeric complexes (Kaupmann et al. 1998).

Low-densities of Kir3 Channel Subunits Are Present on CCK-IN Dendrites
To confirm that the effector Kir3 channels are also present on CCK-containing dendrites, we next performed immunogold labeling for the channel subunits. Peroxidase labeled CCK-IN dendrites showed clear immunoreactivity for all three major Kir3 subunits, albeit to different levels (Fig. 2C-H). Kir3.1 had a mean immunogold density of 7.8 ± 0.9 particles/μm2 (15 dendrites, 2 rats), ~40% lower than that on neighbouring CA1 PC spiny dendrites (12.8 ± 1.3 particles/μm2, 42 dendrites, P=0.02, Fig. 2C,D). Kir3.2 also showed a low intensity of labeling on CCK-IN dendrites, with a mean density of 3.2 ± 0.7 particles/μm2 (12 dendrites, 2 rats), which was over 70% lower than that observed for CA1 PC dendrites (9.9 ± 1.1 particles/μm2, 30 dendrites, P=0.001; Fig. 2E,F). Finally, Kir3.3 subunits had a mean density of 2.4 ± 0.8 particles/μm2 (13 dendrites, 2 rats), again ~70% lower than for that of CA1 PCs (7.3 ± 1.2 particles/μm2, 42 dendrites, P=0.049, Fig. 2G,H). In summary, CCK-INs consistently express surface-localized Kir3 subunits, but at a relatively low density in comparision to CA1 PCs. Furthermore, both GABAB1 and, to a lesser extent, Kir3 channels showed variability in the density of immunogold labeling among CCK dendrites, possibly reflecting a subtype-specific surface localization of membrane-bound GABABRs and Kir3 channels in the CCK-INs.

GABABR-mediated Postsynaptic Currents Are Present in CCK-INs
In order to characterize GABABR- and Kir3-mediated slow inhibitory postsynaptic currents (IPSCs), we made recordings in CA1 of the ventral third of the hippocampus, from acute slices of juvenile Wistar rats (P17-28). IPSCs were evoked by extracellular stimulation to the str.radiatum/lacunosum-moleculare border in the presence of antagonists to ionotropic glutamate receptors (DNQX or NBQX 10 μM and APV 50 μM) and GABAARs (bicuculline or gabazine 10 μM). GABABR-mediated slow IPSCs were recorded from 17 CA1 PCs, as controls, and 41 INs, the latter of which all showed immunoreactivity for CCK (Fig. 4). 
Following extracellular stimuli we consistently observed slow IPSCs with small amplitudes in CA1 PCs, as described previously (; Degro et al. 2015). The mean amplitude of the slow IPSCs evoked by a single stimulus was 8.8 ± 0.6 pA, (Fig. 3A, top); while the kinetics of the IPSCs was characterized by a long onset latency of 48.4 ± 1.0 ms, a rise time of 79.5 ± 2.5 ms and decay time-constant of 128.0 ± 5.1 ms (kinetic parameters derived from 7 cells, see Materials and Methods). The IPSCs in all CA1 PCs were completely blocked by bath application of the GABABR antagonist CGP-55845 (CGP 5 μM, Fig. 3A, bottom). Following the same single extracellular stimulation in CCK-INs we observed slow GABABR-mediated IPSCs (Fig. 3B, top), which were also fully blocked by CGP application (31 cells, Fig. 3B, bottom). The IPSCs had similar kinetics to those in CA1 PCs with respect to onset latency (56.3 ± 3.0 ms), rise time (73.0 ± 2.5 ms), and decay time-constant (141.4 ± 5.2 ms, P>0.05 for all properties, 8 cells). However, CCK-INs had a smaller mean IPSC amplitude of 3.1 ± 0.1 pA, ~65% lower than in CA1 PCs (Fig. 3C). 
When trains of 3-5 stimuli (at 200 Hz) were applied, the responses showed an almost linear increase in amplitude (Fig. 3A,B). In PCs the mean amplitude in response to a train of 5 stimuli was 36.3 ± 2.3 pA, whereas in CCK-INs a proportionally smaller response of 15.4 ± 0.5 pA, approximately 5-times the amplitude of the single-stimulus evoked IPSCs, was observed (P=0.0008, Mann-Whitney test, Fig. 3C). Interestingly, in CA1 PCs the decay time-constant of GABABR-mediated IPSCs grew increasingly longer with higher number of stimuli (for trains of 5 stimuli: 156.3 ± 2.9 ms, P=0.005, Wilcoxon matched-pairs test). In contrast, in CCK-INs the decay time-constant did not increase, but rather moderately, albeit not significantly, decreased (for trains of 5 stimuli: 116.1± 5.7 ms, P=0.156 Wilcoxon matched-pairs test, Fig. 3D). The observed divergence in IPSC decay kinetics as a function of stimuli number between PCs and CCK-INs was highly significant (P=0.0027, 2-way ANOVA). The faster decay kinetics observed in CCK-INs may indicate that desensitization of the GABABR-mediated response may counterbalance the prolongation of currents at the higher GABA concentrations resulting from sustained synaptic activity.
Both PCs and CCK-INs showed a large variability in amplitudes of the slow IPSCs with a moderately higher coefficient of variation (CV) in the interneurons (134% vs 100%, for IPSCs evoked by trains of 5 stimuli in CCK-INs vs PCs, respectively). As it is known that dendritic filtering and insufficient space clamp may alter the amplitude of synaptically evoked responses at large electrotonic distance from the somatic recording site, we tested whether we can find any evidence for such systemic bias in our recordings from CCK-INs. However, there was no correlation between the somatic distance from the str. radiatum/lacunosum-moleculare border, corresponding to the stimulation site, and the recorded IPSC amplitudes (correlation coefficient R2 = 0.007; Supplementary Fig. 2).

CCK-INs Are Morphologically and Physiologically Diverse and Include BCs as well as DT Interneuron Types
As the amplitudes of GABABR-mediated IPSCs in CCK-INs were more heterogeneous than in CA1 PCs, we asked whether morphological subtypes of CCK-IN possessed divergent GABABR-induced responses, as previously shown for PV-INs (). Therefore, we next visualized and analyzed the morphological properties of 49 visualized CCK-INs. In 8 cells, the axon was cut close to the soma and these cells were excluded from further analysis. From the remaining 41 cells, those with the most complete dendritic and axonal arbors were chosen for reconstructions. CCK-INs typically showed a great degree of variability with regard to their dendritic as well as axonal distributions (Fig. 4). BCs are a major subtype of CCK-IN (Cope et al. 2002; Pawelzik et al. 2002; Klausberger et al. 2005) with axons found in and around str. pyramidale (Fig. 4A). We identified 13 BCs, of which 7 were reconstructed and dendritic and axonal distributions quantitatively examined (Fig. 4A,E). DT CCK-INs are more diverse and include SCA cells (16 cells, 8 reconstructed) with axon in str. radiatum and str. oriens (Fig. 4B,E) and PPA neurons (6 cells, 4 reconstructed) (Fig. 4C,E) projecting to the str. lacunosum-moleculare (Vida et al. 1998; Cope et al. 2002). With respect to their intrinsic physiological properties these 3 types were broadly similar, albeit with higher discharge frequencies seen in DT types when compared to BCs (Fig. 4, Supplementary Table 1).
In addition to these known subtypes, we identified 5 CCK-INs with a previously undescribed axonal projection, which was restricted to and around the str. lacunosum (Fig. 4D). Str. lacunosum is a thin layer between the str. moleculare and str. radiatum, but is often regarded together with the former layer as str. lacunosum-moleculare. This layer is characterized by a less homogenous neuropil structure than the two adjacent layers and contains irregularly arranged neurons and numerous myelinated fibers (Cajal 1911). The axon of these interneurons was less extensive than those of the other types, but spanned the full 300 m depth of the slices. Axon collaterals were running in and near this layer parallel to the layer boundaries. On the basis of these morphological features, we propose these cells as a novel IN type and refer to them as lacunosum-axon (LA) cells.
LA cells had cell bodies in or near the str. lacunosum, a multipolar dendritic tree dominated by long horizontal dendrites and their axons were predominantly located in str. lacunosum and, to a lesser degree, the outer 1/3 of str. radiatum, with only a few axon collaterals running into str. moleculare (Fig. 4D,E). Finally, LA cells had intrinsic physiological properties largely similar to those of other CCK DT cells (Fig. 4, Supplementary Table 1), albeit with a greater voltage-sag in response to hyperpolarizing pulses, suggestive of larger HCN channel-mediated currents ().
As CCK-INs are known to express high levels of cannabinoid 1 (CB1) receptor in their axon terminals (Katona et al. 1999; Dudok et al. 2015) and CB1 receptor shows a higher intensity labeling in and near the str. lacunosum (Rivera et al. 2014), we asked if the axon of LA cells also express this receptor at high levels. Indeed, similarly to BC axons (3 BCs tested as control) immunolabeling indicated consistent presence of the receptor in 3 tested LA cells (data not shown). These results indicate that LA cells comprise a morphologically and physiologically distinct CCK-IN subtype.
Morphologically-defined Populations of CCK-IN Show Divergent GABABR/Kir3-mediated Slow IPSCs
We next assessed whether the GABABR-mediated IPSCs in CCK-INs showed subtype-specific differences. Identified CCK BCs had mean GABABR-mediated IPSC amplitudes of 5.5 ± 0.5 pA and 30.4 ± 2.8 pA in response to single stimuli or trains of 5 stimuli (10 BCs, in 3 of the recovered BCs monosynaptic IPSCs were not collected). These values were comparable to those observed in CA1 PCs (P=0.63 and 0.91, respectively, Mann-Whitney test, Fig. 5A,E). By contrast, in SCA INs (15 cells) the same stimuli produced slow IPSCs of 1.8 ± 0.1 pA and 6.7 ± 0.4 pA, respectively, substantially smaller than those in BCs (P=0.014 and 0.004, respectively, Mann-Whitney test, Fig. 5B,E). PPA INs (6 cells) had evoked IPSC amplitudes of 4.7 ± 0.5 pA and 22.6 ± 6.1 pA, smaller, but not significantly different from those of BCs (P=0.96 and 0.56, respectively, Mann-Whitney tests, Fig. 5C,E). Finally, GABABR-mediated IPSCs recorded in LA INs (5 cells) had mean amplitudes in response to 1 and 5 stimuli of 1.6 ± 0.4 pA and 2.9 ± 0.9 pA, which were much smaller than those observed in BCs (P=0.02 and 0.005 respectively, Mann-Whitney test, Fig. 5D,E). In all types, the slow IPSC was blocked by bath application of CGP (5 µM).
To confirm that the reduced IPSC amplitude observed in CCK DT-INs was not due to differing portions of the dendritic tree near to the stimulation site, we compared the distribution of the dendrites of each cell type to the amplitude of the IPSCs. This analysis revealed that there was a moderate positive correlation between IPSC amplitude and the proportion of dendrites found within str. radiatum and lacunosum-moleculare for CCK BCs (R2= 0.46; Supplementary Fig. 3). However for the other CCK-IN types, there was little correlation (R2=0.03; Supplementary Fig. 3). In fact, for PPA and LA cells, essentially all dendrites were located in these two layers, but showed consistently low IPSC amplitudes. 
In summary, CCK BCs possess functional GABABR-mediated currents comparable to those in CA1 PCs. By contrast, CCK DT cells appear to have variable GABABR-mediated IPSCs with the majority of DT cells having synaptic responses substantially smaller than those of both CCK BCs and CA1 PCs.

Divergent Activation of Agonist-induced GABABR/Kir3 Whole-cell Currents in Morphologically Identified CCK Subtypes
It has been previously shown that extracellular stimulation of monosynaptic IPSCs does not activate the entire complement of functional GABABRs of a cell  ADDIN EN.CITE (; ; Degro et al. 2015). Therefore, to measure the full whole-cell current (IWC) mediated by GABABRs in CCK-INs we bath applied the selective GABABR agonist baclofen (10 μM). To confirm that baclofen-mediated IWC was indeed specific to GABABR, we subsequently applied CGP (5 μM) to the bath. As has been shown previously  ADDIN EN.CITE (; ; ), CA1 PCs responded to baclofen wash-in with a large outward IWC (Fig. 6A,F) with a mean amplitude of 73.1 ± 3.7 pA (12 cells), close to the value we have previously obtained under similar conditions (). Subsequent bath application of CGP fully blocked this baclofen-induced current and produced a small inward shift in IWC relative to baseline, indicating a small, but non-significant tonic GABABR-mediated current (‑21.5 ± 4.2 pA, P=0.25, 9 cells) under baseline conditions in the recorded cells. 
Consistent with the IPSC data, CCK-IN types had variable baclofen-induced IWC. In BCs (9 cells) the average peak baclofen-induced IWC was 69.3 ± 4.1 pA (Fig. 6B,F), very similar to that in CA1 PCs (P=0.97, Mann-Whitney test) confirming that CCK-BCs have comparable GABABR-mediated responses to PCs. By comparison, all 3 DT CCK-IN types had substantially smaller peak baclofen-induced currents, which were at least 60% lower than those of CCK BCs or PCs. SCA cells (16 cells) had a mean peak amplitude of 23.9 ± 1.1 pA (Fig. 6C,F), PPA cells (5 cells) responded with 26.4 ± 6.1 pA (Fig. 6D,F), and LA cells (5 cells) with 14.1 ± 3.1 pA (Fig. 6E,F). Statistical analysis confirmed that there was no significant difference in baclofen-mediated response among the DT types (P=0.52, Kruskal-Wallis test, Fig. 6F). In contrast when compared to CCK BCs, all three DT subtypes exhibited highly significant differences (P=0.0004, 0.02 and 0.001, respectively, Mann-Whitney test, Fig. 6F). To examine whether IWC amplitudes correlated with the recorded IPSC amplitudes, we plotted the two amplitudes for both CCK-INs and PCs (Supplementary Fig. 4). In both cell types there was a strong correlation between IPSC amplitude and IWC (for CA1 PCs R2=0.70; for CCK-INs R2=0.43), suggesting that IPSC amplitudes as well as IWC are good indicators of functional GABABR expression. In all CCK-INs, subsequent bath application of CGP fully blocked baclofen-induced IWC, but did not reveal any tonic current (P>0.05 all, Wilcoxon signed-rank test).
In summary, CCK-INs show variable responses to pharmacological activation of GABABRs: CCK-BCs have consistently large amplitude GABABR-mediated responses, while CCK-DT subtypes typically have smaller amplitude responses.

CCK-INs Show Strong Desensitization of Baclofen-induced Currents and High Expression of KCTD12 Proteins
In most recordings from CCK-INs, we observed a rapid reduction in IWC following the initial peak of the baclofen-induced response during bath application, which appeared to be largely absent in CA1 PCs (Fig. 7). In all CCK-INs tested the baclofen-induced IWC reduced greatly over the 10 minutes of agonist application (Fig. 7A). The steady-state amplitude of IWC in CCK-INs was 47 ± 1% smaller than the peak amplitude (32 cells, Fig. 7A). By contrast, in CA1 PCs the IWC was reduced only by 8.3 ± 0.5% over the same time window (26 cells, P=0.0004, Mann-Whitney test, Fig. 7B). The desensitization observed was independent of the CCK-IN subtype as a similar degree of reduction in IWC was seen in BC as well as DT cell types: IWC in CCK BCs reduced by 38.4 ± 3.2% (8 cells), SCA cells by 50.8 ± 3.2% (14 cells), PPA cells by 58.7 ± 10.3% (5 cells), and LA cells by 42.0 ± 6.6% (5 cells, Fig. 7C, P>0.05, Kruskal-Wallis test). 
KCTD12, an intracellular auxiliary subunit of GABABRs, has been shown to play a central role in regulating the desensitization of the GABABR-Kir3 currents (). To address whether this protein is present in CCK-INs, we performed immunogold labeling for KCTD12 and analyzed the distribution of the protein in dendritic shafts of CCK-INs and CA1 PCs (Fig. 7D,E). In CCK-IN dendrites, we observed a high density of immunoparticles for KCTD12 at the plasma membrane as well as in the cytoplasm (Fig. 7D). Quantification of KCTD12 immunoreactivity showed a membrane surface density of 60.2 ± 7.4 particles/μm2 in CCK-immunoperoxidase positive dendrites (17 dendrites). This was 6-fold higher than for the spiny dendrites of CA1 PCs in the same sections, which had a mean density of 10.4 ± 1.0 particles/μm2 (19 dendrites, P<0.0001, Mann-Whitney test, Fig. 7E). 
Thus, CCK-INs selectively express KCTD12 protein at high levels, in good agreement with the strong desensitization observed in these INs. Furthermore, the results obtained indicate that KCTD12-induced desensitization is likely to be specific to CCK-INs, as PV-INs recorded under identical conditions (Booker et al. 2013) showed desensitization profiles similar to those in CA1 PCs (15.2 ± 6.1%; 11 cells, P=0.44, Mann-Whitney test), and much lower than what was observed in CCK-INs (P<0.0001, Mann-Whitney test, Fig. 7; Supplementary Fig. 5).

KCTD12 Proteins Modulate Desensitization as well as Amplitude and Kinetics of GABABR/Kir3-mediated Currents in CCK-INs
In order to confirm that KCTD12 was the major factor determining the desensitization of GABABR/Kir3-mediated currents, we next recorded baclofen-induced currents in CCK-INs from knock-out mice, which lack the KCTD12 protein (KCTD12 KO) (Cathomas et al. 2015). CCK-INs from KCTD12 KO mice did not display differences in resting membrane potential or action potentials threshold in comparison to wild-type (WT) littermate mice (P>0.05, Supplementary Fig. 6A,D). However, there was an increase in input resistance (RI) from 159.7 ± 18.9 MΩ in WT mice to 227.0 ± 26.4 MΩ (P=0.049, Mann-Whitney test) in the KCTD12 KO animals (Supplementary Fig. 6B). Consistent with this change in the RI, the rheobase of recorded neurons was substantially decreased (P=0.013, Mann-Whitney test, Supplementary Fig. 6C). The observed difference in Rl of CCK-INs between WT and KCTD12 KO mice is in good agreement with our recent observation that the presence of KCTD12 leads to an increase in barium-sensitive tonic K+ current in CA1 PCs, independent of known interaction with GABABRs (Cathomas et al. 2015). 
Baclofen-induced IWC were recorded as above, with CCK-INs in WT mice showing similar responses, which peaked <1 minute after bath application of the agonist, then rapidly decaying to a steady state level within 2-3 minutes (Fig. 8A). This steady state current was fully reversed by 5 µM CGP application. The same protocol in CCK-INs from KCTD12 KO mice (Fig. 8B) showed a similar onset of GABABR-mediated IWC, however the IWC showed no substantial decay. 
The mean peak IWC recorded in CCK-INs was 78.1 ± 12.0 pA for KCTD12 KO mice (14 cells) and 56.4 ± 10.2 pA in WT littermates (11 cells), which was lower albeit not significantly so (P=0.26, Mann-Whitney test, Fig. 8C). The measured steady-state IWC of 71.7 ± 11.6 pA in CCK-INs from KCTD12 KO mice was very similar to that of the peak response (P=0.76, Mann-Whitney test), and much larger than observed in WT mice (31.6 ± 8.4 pA, P=0.011, Mann Whitney test). As expected from the divergence of steady state IWC, the measured desensitization was much smaller in KCTD12 KO mice (7.3 ± 4.5%) compared to WT mice (46.7 ± 11.3%, P=0.002, Mann-Whitney test, Fig. 8D). Despite the species difference, the average desensitization seen in CCK-INs in WT mice was comparable to that observed in the rat (P=0.85, Mann-Whitney test). Thus, these data confirm that the strong desensitization observed in CCK-INs is dependent on the presence of KCTD12 in these cells.
Finally, to investigate whether KCTD12 can directly influence kinetics of GABABR-mediated responses produced by endogenous GABA release, we compared slow IPSCs elicited by extracellular stimulation to the str. radiatum/lacunosum-moleculare border in CCK-INs from WT vs KCTD12 KO mice (Fig. 8E). Single extracellular stimuli resulted in IPSC with a mean amplitude of 8.0 ± 2.8 pA (9 cells) and a decay time-constant of 197.3 ± 22.1 ms in CCK-INs from WT mice. In INs from KCTD12 KO mice, the mean IPSC amplitude was markedly smaller (4.4 ± 1.5 pA, 14 cells, P=0.02, Fig. 8F) and the kinetics was substantially slower with a mean decay time-constant of 348.2 ± 48.2 ms (P=0.04, Mann-Whitney test, Fig. 8G). Furthermore, the onset latency and rise time of the IPSCs were significantly longer in KO than in WT mice (Supplementary Fig. 6E,F). These differences in the amplitude and kinetics remained consistent for GABABR-mediated IPSCs evoked by trains of 3 or 5 stimuli delivered at 200 Hz: IPSCs were smaller  (P=0.029, 2-way ANOVA, Fig. 8F) and had longer decay time-constants in CCK-INs from KCTD12 KO mice than WT littermates (P=0.0003, 2-way ANOVA, Fig. 8G). These data suggest that KCTD12 directly modulates GABABR-mediated inhibition arising from endogenous GABA release. 
In summary, these results demonstrate that KCTD12 is highly expressed in CCK-INs and determine the desensitization as well as amplitude and kinetics of GABABR-mediated IPSCs in CCK-INs. 

Discussion
This study shows that CCK-INs in the CA1 area of the rat hippocampus express major functional elements of the GABABR-signaling cascade: GABABRs and the auxiliary protein KCTD12 are present at high levels on extrasynaptic membranes of CCK-IN dendrites, whereas the effector Kir3 channels are expressed to a lesser degree and may thereby determine the maximal postsynaptic current amplitude. Our study further shows that CCK-INs in CA1 area are morphologically more diverse than previously known and reveals a dichotomy in GABABR-mediated inhibitory postsynaptic currents, with large responses observed in CCK BCs, and markedly smaller responses in DT cell subtypes. Finally, KCTD12 plays a major role in desensitization of GABABR/Kir3-mediated inhibitory currents in CCK-INs during sustained activation of the receptors and can modulate the amplitude as well as the kinetics of IPSCs during phasic GABA release.

Morphological Diversity of CCK-INs
It is well established that cortical INs are highly heterogeneous with respect to their neurochemical, physiological, and morphological properties. Dendritic and axonal arborizations of the diverse types are optimized for specific input and output processing and thereby define their roles in neuronal circuit ADDIN EN.CITE  (; ; ; ). CCK-INs comprise a major subset of INs, approximately 15% of all GABAergic neurons  ADDIN EN.CITE (; Nunzi et al. 1985) and are known to include morphologically and physiologically distinct perisomatic inhibitory BCs and various DT types  ADDIN EN.CITE (; ; ; ; ; Glickfeld and Scanziani 2006; ). In this study, we confirm the diversity of CCK-INs and identify a novel LA IN type in the CA1 area, which shows a selective axonal arborization in and near the str. lacunosum with distinct electrophysiological properties. This axonal distribution is in good agreement with prior evidence that CCK immunoreactivity shows a band of axonal labeling in the str. lacunosum  ADDIN EN.CITE (; ; ) as well as a strong expression of vesicular glutamate transporter-3 and CB1 receptor in the same lamina, both proteins known to be present in axon terminals of most CCK-IN types  ADDIN EN.CITE (Herzog et al. 2004; ). In addition to their unique axonal arborisation pattern LA cells exhibit distinct electrophysiological properties, notably a large hyperpolarization-activated sag, which likely reflects a large Ih current (Maccaferri and McBain 1996) that in turn may confer stronger theta resonance to those cells. The observed differences between BC and DT types add to recent evidence indicating that CCK-INs show region-specific differences in their morphology, target specificity, and synaptic output producing divergent network activity  ADDIN EN.CITE (; ).

GABABRs Are Highly Enriched in CCK-INs
The strong immunofluorescence labeling for the GABAB1 subunit in the somata of CCK-INs observed in this study is consistent with previous immunocytochemical results (). This is paralleled by a high density of receptor subunit at the plasma membrane of CCK-immunoreactive dendritic shafts. For surface localization and formation of functional receptors, the GABAB1 subunit needs to heterodimerize with GABAB2 (). The high expression of GABAB1 at the membrane surface is therefore indicative of functional receptors (), whereas the somatic intracellular signal may reflect an endoplasmic pool of the GABAB1 protein (). Thus, we show conclusively that CCK-INs have larger functional and intracellular pools of GABABRs than CA1 PCs or PV-INs (), plausibly reflecting higher production, trafficking, and turn-over of GABABRs in these INs. 
The majority of surface-localized GABABR subunits were extrasynaptic, supporting that activation of GABABRs in CCK-INs requires spill-over of GABA from inhibitory synapses, as has been described for other neurons  ADDIN EN.CITE (; ; Oláh et al. 2009; ). The source of GABA, capable of producing significant activation of GABABRs, remains ambiguous. Neurogliaform and Ivy cells with their dense and focal axon are likely sources of GABA  ADDIN EN.CITE (; ; ), however, other dendrite-targeting INs may also contribute  ADDIN EN.CITE (; ). 

Low Expression of Kir3 Channel Subunits may Limit the Functional GABABR-mediated Postsynaptic Currents in CCK-INs
It is well established that postsynaptic GABABRs preferentially activate Kir3 channels  ADDIN EN.CITE (; ; ; ; ; ). Kir3 channels are generally heteromultimers, with Kir3.2 believed to be the constitutive subunit in the brain () necessary for surface localization and formation of functional channels in combination with Kir3.1 and/or Kir3.3 (). Consistent with this hypothesis, we found Kir3.1, Kir3.2 as well as Kir3.3 channel subunits on the dendritic membranes of CCK-INs, albeit at densities markedly lower than in CA1 PCs. Indeed, the fact that Kir3.2 labeling was ~3-fold lower than in CA1 PCs may explain why GABABR-mediated functional currents were of similar amplitude, despite a considerably higher surface localization of GABABRs. Accordingly, Kir3 channels may be the limiting factor for GABABR-induced postsynaptic currents in CCK-INs, where signaling from a large number of GABABRs converges onto a smaller number of Kir3 channels, similar to the situation in some subcellular compartments of hippocampal principal cells (Degro et al. 2015). In this case, little room may be left for convergent activation of Kir3 channels by other neuromodulatory receptors, i.e. endocannabinoid or muscarinic receptors  ADDIN EN.CITE (; Hajos et al. 2000; ). Excess GABABRs on CCK-IN dendrites may act through alternative signaling pathways, such as the inhibition of voltage-sensitive calcium channels  ADDIN EN.CITE (; ) or NMDA receptors ().

Differential Postsynaptic GABABR-mediated Effects in CCK-IN Types
We demonstrate here that larger GABABR/Kir3-mediated currents are present in CCK BCs than in CCK DT cell types. In line with our previous data (), it is emerging that perisomatic-targeting INs consistently exhibit large amplitude GABABR/Kir3-mediated postsynaptic inhibitory effects, whereas DT cell types, both CCK- and PV-containing, do not. It is tempting to speculate that, in light of the potential role of GABABRs in the control and maintenance of network activity  ADDIN EN.CITE (; ; ; ), GABABRs may serve multiple and dynamically-changing network functions in INs. Synchronized low frequency discharge of large IN sets, for example during theta oscillations (Scanziani 2000), could lead to GABA spill-over, a fluctuation between low and high ambient GABA concentrations and rhythmic GABABR activation. A phasic inhibition of BCs by GABABR-mediated K+ currents under these conditions would stabilize and enhance slow oscillatory activity (Booker et al. 2013). By contrast, when global GABAergic activity is heightened, increasing tonic activation of GABABR onto BCs could lead to a shift in the balance of dendritic vs perisomatic inhibition, resulting in reduced BC activity and thereby diminishes entrainment of PCs to high frequency oscillations  ADDIN EN.CITE (; ). At the same time, maintained levels of dendritic inhibition, mediated through both GABAARs and GABABRs, will prevent disinhibition of PCs and can in fact dampen population activity, reduce synaptic transmission as well as plasticity. 
The differential effects of GABABR/Kir3 in CCK-INs are particularly relevant when one considers inhibitory inputs onto the somatodendritic domain of these cells. CCK-INs possess up to 35% of their total synaptic inputs in the form of symmetric GABAergic synapses  ADDIN EN.CITE (Taki et al. 2000; ). It could be hypothesized therefore that inhibition in DT subtypes is preferentially mediated by GABAARs, whereas BCs receive a more complex inhibitory modulation, comprising synaptic GABAAR and extrasynaptic GABABR components, leading to greater patterning of cell activity. What contribution different GABAAR subtypes and GABABRs make to the total inhibition of CCK BC and DT INs, however, requires further investigation.


High Expression of KCTD12 Protein Underlies Desensitization of GABABR/Kir3-mediated Currents in CCK-INs
Proteins of the KCTD family have been recently shown to directly associate with GABABRs and regulate GABABR response kinetics  ADDIN EN.CITE (; ). KCTD12 has been found to be highly expressed in a subpopulation of hippocampal INs in str. radiatum of CA1 (), but their identity remained unknown. Our results now demonstrate that CCK-INs possess a high level of dendritic KCTD12, which correlates with a strong and fast desensitization of GABABR/Kir3-mediated currents during prolonged baclofen application and faster GABABR-mediated IPSC decay kinetics in response to phasic endogenous GABA release. This is contrasted by the lower desensitization profile (Turecek et al. 2014) and a prolonged decay of IPSCs (present results) observed in CA1 PCs, which contain lower KCTD12 protein levels. In fact, the electrophysiological data obtained from KCTD12 KO mice directly show that KCTD12 is a major factor determining the desensitization of GABABR/Kir3-mediated responses, both synaptic and pharmacological, in CCK-INs. Furthermore, the much lower level of desensitization of GABABR-mediated currents in PV-BCs, also known to have large GABABR currents (), suggests that this effect is largely confined to CCK-INs.
Interestingly, KCTD12 has also been shown to increase the surface expression of GABABRs (). Therefore, it is tempting to speculate that the high GABABR surface expression observed in CCK-INs is due in part to the abundance of KCTD12 in these INs, while the consistent low expression of Kir3 subunits acts to control the functional currents. Indeed, the reduced GABABR-mediated IPSC amplitudes in CCK-INs from KCTD12 KO mice, as compared to WT mice, would suggest that there may in fact be a reduced density of functional GABABR/Kir3 complexes in the KO animals. Furthermore, CCK-INs from KCTD12 KO mice recapitulate some, but not all, of the intrinsic physiological differences detected previously in CA1 PCs. We observed an increase in Rl, which was previously attributed to a reduction in a Ba+-sensitive tonic K+ current in PCs (Cathomas et al. 2015). In contrast to PCs, however, no difference was observed in action potential threshold in CCK-INs, indicating that KCTD12 alters neuronal excitability in a cell-type specific manner.
KCTD12 protein shows association with mental diseases, including schizophrenia, major depressive disorder, and bipolar disorder (). In good agreement, transgenic KCTD12-deficient mice exhibit behavioral phenotypes of altered emotionality and homeostatic behaviors that correlate with altered excitability of hippocampal PCs (). The high KCTD12 expression and its robust physiological effects observed in our experiments strongly suggest a complementary involvement of CCK-INs in the etiopathology of those neuropsychiatric disorders. 
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Figure legend

Figure 1. CCK-INs show immunoreactivity for GABAB1 and Kir3 subunits. (A) Images of the CA1 area of the rat hippocampus showing immunoreactivity for both CCK (green pseudocolor, left) and GABAB1 (red, middle; superimposed images on the right). Note the strong immunolabeling for GABAB1 in all CCK-positive somata (arrowheads) compared to neighboring CA1 PCs. (B) Colocalization of CCK (green, first column) with either Kir3.1, Kir3.2, and Kir3.3 subunits (blue, second column) and GABAB1 (red, third column, superimposed images are in the fourth column) in CA1 INs. CCK-immunoreactive somata show labeling for all three Kir3 subunits in combination with GABAB1, albeit with variable intensity. (C) Quantification of the fluorescence intensity of GABAB1, Kir3.1, Kir3.2, and Kir3.3 in CCK-INs and PCs in CA1, shown in arbitrary units (A.U). The mean intensity of neuropil labeling is shown as a dashed line. Layers shown: Mol – str. moleculare, Lac – str. lacunosum, Rad – str. radiatum, Pyr – str. pyramidale, Ori – str. oriens. Scale bars: A top: 50 μm; B: 10 μm.

Figure 2. High density of GABAB1, but low density of Kir3 channel subunits in dendritic shafts of CCK-INs. (A) Consecutive electron micrographs showing strong immunoreactivity for GABAB1 (immunogold particles, arrowheads) in a CCK-positive dendrite (Den, peroxidase reaction end-product), contacted by a presynaptic bouton (b), in str. radiatum of the CA1 area. The majority of immunogold particles were found on the extrasynaptic plasma membrane. Note the immunoreactivity for the receptor subunit in dendritic spines (s) of neighboring putative PCs. (B) Summary bar chart shows that the surface density of immunogold particles labeling the GABAB1 subunit was substantially higher in CCK-INs than in immunoperoxidase-negative spiny dendrites of PCs in the same images. (C,E,G) Consecutive serial electron micrographs demonstrating the localization of immunogold particles (arrowheads) for Kir3.1 (C), Kir3.2 (E), and Kir3.3 (G) on CCK-positive dendrites (Den, peroxidase reaction end-product). (D,F,H) Quantification of surface density of immunogold particles on CCK-IN dendrites and peroxidase negative spiny dendritic shafts of CA1 PCs labeled for the respective Kir3 subunits. Bar charts show mean ± SEM with the individual values superimposed as open circles. Scale bars: 500 nm. Statistics shown: * - P<0.05, ** - P<0.01, *** - P<0.001, Mann-Whitney tests.

Figure 3. CCK-INs express GABABR-mediated slow IPSCs. (A) Extracellular stimuli delivered to the str. radiatum/lacunosum-moleculare border (inset schematic) resulted in large amplitude slow IPSCs in CA1 PCs following single stimuli (upper trace) or trains of 5 stimuli (middle trace, at 200 Hz) both at 50 V intensity. IPSCs were completely blocked by bath application of the selective GABABR antagonist CGP (bottom trace). (B) Slow IPSCs (upper trace) were observed in INs immunoreactive for CCK (inset, green pseudocolor; biocytin labeled soma in blue). IPSCs in CCK-INs were also blocked by CGP application (bottom trace). (C) GABABR-mediated IPSC amplitude plotted for all three stimulus (stim) levels for CA1 PCs (black circles) and CCK-INs (open circles). Individual data from each cell recorded is shown alongside the mean value and the number of cells contributing to each group is indicated in parenthesis below (CA1 PC, CCK-IN). (D) Decay time-constant of the slow IPSC plotted for CA1 PCs and CCK-INs as in panel C. Statistics shown: ns – P>0.05, * - P<0.05, ** - P<0.01, *** - P<0.0001; 2-way ANOVA with Bonferroni multiple comparisons. Inset scale bar: 10 μm.

Figure 4. Distinct morphological subtypes of CCK-INs in CA1 area of the hippocampus. (A) Reconstruction of a CCK-BC, with a dense axonal arbor (red) in and around str. pyramidale (Pyr) with the somatodendritic domain (black) found in str. oriens (Ori), radiatum (Rad), lacunosum (Lac) and moleculare (Mol). Inset (top right), the biocytin-labeled soma (bioc, blue pseudocolor) of this cell was strongly immunoreactive for CCK (green, top). Inset (bottom right) shows voltage responses to a family of hyper- to depolarizing current injections. Note that the cell showed a regular discharge pattern. (B) Morphological and physiological characterization of a CCK-immunoreactive SCA cell. Note this cell had a dense axon in str. oriens and radiatum and regular spiking phenotype. (C) A similar illustration of a PPA IN with axon in str. lacunosum-moleculare. (D) LA type INs had an axon, which was largely confined to str. lacunosum. Likewise, the somatodendritic domain was localized to the same region. LA cells responded to hyperpolarizing current injections with a large voltage-sag, unlike other CCK-INs. (E) Summary bar charts of the axonal and dendritic distributions of CCK-IN types in the CA1 layers expressed as percentages (see also Supplementary Table 1). Inset scale bars: 10 μm. 

Figure 5. GABABR/Kir3-mediated IPSCs in morphologically identified CCK-IN subtypes. (A) Slow IPSC in a CCK BC elicited by 200 Hz train of 5 stimuli applied via an extracellular electrode placed at the border of str. radiatum and lacunosum-moleculare (top trace). (B,C,D) Representative traces illustrating the slow GABABR/Kir3-mediated IPSCs in DT SCA, PPA, and LA types of CCK-INs. The selective GABABR antagonist CGP fully blocked the outward current (bottom traces). (E) Summary bar chart of the GABABR-mediated IPSC amplitudes recorded from the different CCK-IN types. Number of recorded cells is shown in parenthesis. Bar charts show mean ± SEM overlain by data from individual cells (open circles); the amplitude of IPSC produced by CA1 PCs is shown as a dashed line for reference. Note that the mean IPSC in SCA and LA cells was significantly smaller than that of BCs. Statistics shown: ns – P>0.05, ** - P<0.01, *** - P<0.001, Mann-Whitney test.

Figure 6. GABABR-mediated IWC is differentially expressed by morphologically defined CCK-INs. (A) Time course plot of IWC before and during sequential bath application of the GABABR agonist baclofen (10 μM, filled bars) and the antagonist CGP (5 μM, unfilled bars) from a subset of CA1 PCs (PC, n=12 cells). Note the large amplitude outward (positive) current induced by baclofen, which is subsequently fully blocked by CGP. (B) The same protocol also elicited large change in IWC in CCK BCs (BC, n=9). (C-E) Small baclofen-induced currents were observed in SCA cells (n=16) as well as in PPA (n=5) and LA (n=5) cells. (F) Summary bar graph of the baclofen-induced IWC measured in CA1 PCs and CCK-IN types. Bars are overlain by data from individual cells (open circles). Note CA1 PCs and CCK BCs had similar IWC changes, whereas all CCK DT subtypes had smaller responses. Statistics shown: ns – P>0.05, * - P<0.05, *** - P<0.001; Mann-Whitney and Kruskal-Wallis tests.

Figure 7. Strong desensitization of GABABR-mediated currents correlates with high expression of KCTD12 in CCK-IN dendrites. (A,B) Representative time-course plots of the 10 μM baclofen-induced IWC during wash-in and steady-state in a CCK-IN (A) and a CA1 PC (B). Data shown as individual IWC responses at 20 second intervals (open circles) and 1 minute average response (red dashed line). Note the fast and strong desensitization of the GABABR-mediated response in the CCK-IN. (C) Summary bar chart of the mean level of desensitization in CA1 PCs and CCK-IN types. Number of cells examined for each type is shown under the respective bar. (See also Supplementary Fig. 5). (D) Consecutive serial electron micrographs showing the high density of KCTD12 immunolabeling (gold particles) along the plasma membrane and in the cytoplasm of a CCK-IN dendrite (Den, peroxidase reaction end-product), contacted by presynaptic boutons (b). (E) Quantification of immunogold surface density for KCTD12 at the plasma membrane of dendritic shafts of putative PCs and CCK-INs. Bar charts show mean ± SEM overlain by data from individual dendrites (open circles). Scale bar: 500 nm. Statistics shown: ns – P>0.05, *** - P<0.001, Mann-Whitney and Kruskal-Wallis tests.

Figure 8. Desensitization of pharmacological and synaptic GABABR/Kir3 currents in CCK-INs is absent in KCTD12 KO mice. (A,B) Representative time-course plots of baclofen-induced IWC (10 µM) during wash-in and steady-state showing a strong desensitization in WT (A) but not in KCTD12 KO (B) animals. Subsequent CGP (5 μM) application fully blocked the current in both genotypes. Inset, both INs (soma, in blue pseudocolor) were strongly immunoreactive for pre-pro-CCK (CCK, in green). (See also Supplementary Fig. 1). (C,D) Summary bar charts of the peak IWC amplitude (C) and the degree of desensitization (D) in CCK-INs from WT and KCTD12 KO mice. Number of cells tested for each subtype is shown under the respective bar. Note that while the measured peak amplitudes are comparable, the desensitization was strongly reduced in KO mice, as compared to WT. Bar charts show mean ± SEM overlain by data from individual cells (open circles). (E) Representative GABABR-mediated IPSCs following single stimuli to the str. radiatum/lacunosum moleculare border, showing that IPSCs in CCK-INs from WT mice (upper, blue trace) were similar to those in the rat, but smaller and of much longer duration in KCTD12 KO mice (lower, red trace). (F) GABABR-mediated IPSC amplitude plotted for all three stimulus (stim) levels for CCK-INs from WT (blue circles) and KCTD12 KO (red circles), with individual replicates shown alongside. Note that the mean IPSC was consistently smaller in the KCTD12 KO mice. (G) At the same three stimulation levels used in (F), the decay time-constant of GABABR-mediated IPSCs did not change in response to increasing stimuli number in either WT or KO mice, despite being consistently larger in the KCTD12 KO mice. Statistics shown: ns – P>0.05, * - P<0.05, ** - P<0.01, ***  - P<0.001 Mann-Whitney and 2-way ANOVA tests.
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